AxiolumeResearch Library / indexAxiolume / Research Library
Source-backed guides with findings, limitations, and references kept in view.
Start here
Start with the foundation, open the featured guide, or follow the library’s newest reviewed addition.
Start with Academy Lesson 01, a plain-language foundation in peptide definitions, evidence levels, and careful claim reading.
Start with Lesson 01Open the featured guide for human studies, safety signals, regulatory context, and company-reported toplines kept together.
Read the featured guideRead the newest reviewed addition, separating discovery and preclinical work from human biomarker evidence and open questions.
Read the latest guideThe full library
The opening Research Library guide follows retatrutide through its mechanism, peer-reviewed human evidence, safety signals, regulatory context, and company-reported toplines.
Reviewed by Axiolume for source coverage, evidence boundaries, and disclosures. It remains general health education, not medical advice or treatment guidance.
Read the Retatrutide guideThis standalone guide separates the product-specific EGRIFTA indication from human studies of VAT, liver-fat measures, safety context, regulatory records, and unresolved questions.
Reviewed by Axiolume for source coverage, evidence boundaries, and disclosures. It remains general health education, not medical advice or treatment guidance.
Read the Tesamorelin guideThis mitochondrial-derived peptide guide separates discovery and preclinical work from human biomarker evidence, registered studies, and the limits of the current record.
Reviewed by Axiolume for source coverage, evidence boundaries, and disclosures. It remains general health education, not medical advice or treatment guidance.
Read the MOTS-c guideThe guide framework
A consistent frame helps readers compare topics without flattening the evidence. Future guides will separate what is known from what is still being studied, then show the source trail behind the explanation.
What the research describes about biological action.
What human studies show, and what they do not answer.
Where the design, sample, or record leaves uncertainty.
The current status, stated carefully and checked before publication.
Plain-language answers to the questions readers bring first.
A visible source trail for the claims and context.
Nearby topics that help a reader keep learning.
Editorial boundaries and any relevant relationships, clearly stated.
Evidence status
For future additions, a label tells you where a piece of work sits in the editorial process. It does not make a claim about a compound.
A current guide reviewed by Axiolume for source coverage, evidence boundaries, and disclosures.
A future library item being checked before publication.
A future topic or category, not a published result.
Category structure
These categories describe how the library will be organized. They are not a list of published articles.
Core concepts for building a useful vocabulary.
Topic guides that require careful sourcing and review.
Ways to read study design, claims, and uncertainty.
Regulatory, laboratory, and editorial context around the record.
Retatrutide, Tesamorelin, and MOTS-c are published Research Library guides. Each keeps its evidence, limitations, regulatory context, and source trail visible.
Weekly Evidence Brief
Get focused Axiolume updates about new research notes and reviewed educational guides. Unsubscribe from any update whenever you choose.